US Patent 7279329 Expression system for producing collagen

Patent 7279329 was granted and assigned to Industrial Technology Research Institute on October, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Industrial Technology Research Institute

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

72793290

Date of Patent

October 9, 2007

Patent Application Number

112503910

Date Filed

October 17, 2005

Patent Citations Received

‌

US Patent 11801286 Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use

Patent Primary Examiner

‌

Rebecca E. Prouty

Patent abstract

A DNA molecule consisting of the nucleotide sequence of SEQ ID NO: 1, which encodes a collagenous (COL1) domain and a C-terminal noncollagenous (NC1) domain of type XXI collagen. Expression systems and methods for the expression of the DNA molecule are also provided.